Basically they have discriminated against the working class, and minorities are a bigger proportion of the working class.” Kulldorff added. “The lockdowns have discriminated against minorities. “The reason that a lot of African Americans have died in New York - which is true - is because the rich people and more affluent were working from home while the working class were exposed.” Some observers and doctors fear that a system is being created that could lead to racial exclusions in the future during a drug shortage or case surge. “I have not seen as one of the risk factors for severe disease and death,” Martin Kulldorff, a Harvard epidemiologist and professor, told The Post. Medical experts said it is correct for COVID treatment to be allocated based who is at the highest risk, but stressed that race was not a biological risk factor. For now, the city is participating exclusively with Alto Pharmacy to distribute the new drugs.
“We are collecting demographic data on COVID antivirals at the request of the city for anonymized data reporting purposes only, as is commonly done with COVID tests and vaccines,” Michael Krueger, a pharmacy rep said. It is unclear if the new “race” guidance has yet to exclude whites from getting treatment, but observers and doctors fear that a system is being created that could lead to racial exclusions in the future during a drug shortage or case surge. policies and institutional practices that perpetuate racial inequity) and White privilege,” it read. Racial equity does not mean simply treating everyone equally, but rather, allocating resources and services in such a way that explicitly addresses barriers imposed by structural racism (i.e. “The … DOHMH is committed to improving health outcomes for all New Yorkers by explicitly advancing racial equity and social justice. NYC admits prioritizing race in distributing COVID tests: leaked emails “The mere fact of having to ask this question is a slippery slope.”īoth patients, who are white, were ultimately granted their prescriptions.įollow the latest news on the Omicron variant with the New York Post’s live coverageĪ recent “Request for Proposals,” form on behalf of the city Department of Health and Mental Hygiene stressed the agency’s commitment to “racial equity.” “In my 30 years of being a physician I have never been asked that question when I have prescribed any treatment,” said the doctor, who requested anonymity. The Department of Health and Mental Hygiene’s guidance applies to both the distribution of monoclonal antibodies and oral antivirals like Paxlovid and Molnupiravir. One Staten Island doctor said he filled two prescriptions for Paxlovid this week and was asked by the pharmacist to disclose the race of his patients before the treatment was authorized. The race-based approach in treatment has already begun to have real-world consequences. “Monoclonal antibody treatments have averted at least 1,100 hospitalizations and at least 500 deaths among people treated in New York City,” the city said in October. The guidance applies to both the distribution of monoclonal antibodies and oral antivirals like Paxlovid and Molnupiravir. 20, which adds that “longstanding systemic health and social inequities” can contribute to an increased risk of dying from COVID-19. The city will “consider race and ethnicity when assessing individual risk,” reads the agency’s official guidance from Dec. New York City will take a patient’s race into account when distributing potentially life-saving COVID treatments, the Department of Health and Mental Hygiene revealed on their website. Weingarten ruined kids’ lives - but she refuses to apologize for not following the scienceĪ ray of hope from the subway on NYC’s recovery NYC has recovered 99% of lost pandemic jobs, gains uneven across economyĬOVID-19 pandemic is no longer a global emergency: WHO
0 kommentar(er)
